Forex News

Canadian Dollar Rises On Higher Oil Prices

Canadian Dollar Rises On Higher Oil Prices

The Canadian dollar strengthened against its major counterparts in the European session on Monday, as oil prices rose amid easing worries over a banking crisis and comments from Russian President Vladimir Putin that he will station tactical nuclear weapons in Belarus.
RTTNews | 704 days ago
Saudi National Bank Chair Al Khudairy Resigns After His Comments On Credit Suisse

Saudi National Bank Chair Al Khudairy Resigns After His Comments On Credit Suisse

The chairman of Saudi National Bank, Ammar Al Khudairy, has resigned days after he commented about Credit Suisse Group AG that allegedly sent the Swiss bank's stock into a tailspin, ending in its subsequent takeover by domestic rival UBS Group. In a statement, Saudi National Bank or SNB, Credit Suisse's largest shareholder, said it has appointed Chief Executive Officer Saeed Mohammed Al Ghamdi...
RTTNews | 704 days ago
Eurozone Bank Lending Growth Weakens In February

Eurozone Bank Lending Growth Weakens In February

Eurozone bank lending to the private sector registered a slower growth in February reflecting weak credit demand amid higher interest rates and subdued economic activity, data from the European Central Bank revealed Monday. The annual growth rate of credit to the private sector slowed to 3.3 percent in February, the slowest since August 2021, from 3.8 percent in January.
RTTNews | 704 days ago
more news
Vertex Pharma Inks Licensing Agreement To Use CRISPR Therapeutics' Gene Editing Technology

Vertex Pharma Inks Licensing Agreement To Use CRISPR Therapeutics' Gene Editing Technology

Biotechnology company Vertex Pharmaceuticals, Inc. (VRTX) and gene editing company CRISPR Therapeutics, Inc. (CRSP) announced Monday that they have entered into a new non-exclusive licensing agreement for the use of CRISPR Therapeutics' gene editing technology, known as CRISPR/Cas9, to accelerate the development of Vertex's hypoimmune cell therapies for type 1 diabetes (T1D).
RTTNews | 704 days ago
Codiak BioSciences Voluntarily Files For Bankruptcy Protection

Codiak BioSciences Voluntarily Files For Bankruptcy Protection

Biopharmaceutical company Codiak BioSciences, Inc. (CDAK) announced Monday that it has voluntarily filed for protection under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware and will seek to pursue a sale process for its assets which is intended to maximize the value of the Company.
RTTNews | 704 days ago

Stay up to date!

Add News to your browser

Extension Picture